Zobrazeno 1 - 10
of 8 745
pro vyhledávání: '"Nakashima I"'
Autor:
Niino M; Department of Clinical Research, National Hospital Organization Hokkaido Medical Center, Sapporo, Japan. Electronic address: niino.masaaki.tc@mail.hosp.go.jp., Isobe N; Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Araki M; Department of Neurology, Kawakita General Hospital, Tokyo, Japan., Ohashi T; Department of Neurology, Kamagaya General Hospital, Kamagaya, Chiba, Japan., Okamoto T; Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan., Ogino M; Department of Neurology, Intractable Neurological Disease Center, Ichikawa Hospital, International University of Health and Welfare, Chiba, Japan., Okuno T; Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan., Ochi H; Department of Intractable Disease and Aging Science, Ehime University Graduate School of Medicine, Toon, Japan., Kawachi I; Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan; Medical Education Center, Niigata University School of Medicine, Niigata, Japan., Shimizu Y; Department of Neurology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan., Takahashi K; Department of Neurology, National Hospital Organization Iou National Hospital, Kanazawa, Japan., Takeuchi H; Department of Neurology, Graduate School of Medicine, International University of Health and Welfare, Atami, Japan., Tahara M; Clinical Research Center and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan., Chihara N; Division of Neurology, Kobe University Graduate School of Medicine, Kobe, Japan., Nakashima I; Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan., Fukaura H; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan., Misu T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan., Miyazaki Y; Department of Clinical Research, National Hospital Organization Hokkaido Medical Center, Sapporo, Japan., Miyamoto K; Department of Neurology, Wakayama Medical University, Wakayama, Japan., Mori M; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan., Kinoshita M; Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan., Takai Y; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan., Fujii C; Department of Neurology, Kansai Medical University Medical Center, Moriguchi, Japan., Watanabe M; Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Fujihara K; Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, Fukushima, Japan.
Publikováno v:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Oct; Vol. 90, pp. 105829. Date of Electronic Publication: 2024 Aug 17.
Autor:
Yamamura T; Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4 Chome-1-1 Ogawahigashicho, Kodaira, Tokyo, 187-8551, Japan. yamamura@ncnp.go.jp., Isobe N; Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan., Kawachi I; Department of Neurology, Brain Research Institute, Niigata University, Chuo-ku, Niigata, 951-8585, Japan.; Medical Education Center, Niigata University School of Medicine, Chuo-ku, Niigata, 951-8510, Japan., Nohara C; Department of Neurology, Ebara Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation, Tokyo, 145-0065, Japan., Miyazaki Y; Department of Clinical Research, National Hospital Organization Hokkaido Medical Center, Sapporo, 063-0005, Japan., Tomita M; Drug Safety Division, Chugai Pharmaceutical Co., Ltd., 1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, 103-8324, Japan., Tsumuraya T; Drug Safety Division, Chugai Pharmaceutical Co., Ltd., 1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, 103-8324, Japan., Yamashita K; Medical Affairs Division, Chugai Pharmaceutical Co. Ltd., Tokyo, 103-8324, Japan., Nakahara J; Department of Neurology, Keio University School of Medicine, Tokyo, 160-8582, Japan., Nakashima I; Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, 983-8512, Japan., Fujihara K; Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, Fukushima, 960-1295, Japan.; Multiple Sclerosis and Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Koriyama, 963-8563, Japan.
Publikováno v:
Neurology and therapy [Neurol Ther] 2024 Oct; Vol. 13 (5), pp. 1361-1383. Date of Electronic Publication: 2024 Jul 16.
Autor:
Yokote H; Department of Neurology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan; Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo, Japan. Electronic address: yktenuro@tmd.ac.jp., Miyazaki Y; Department of Clinical Research, National Hospital Organization Hokkaido Medical Center, Sapporo, Japan., Fujimori J; Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan., Nishida Y; Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo, Japan., Toru S; Department of Neurology, Nitobe Memorial Nakano General Hospital, Tokyo, Japan., Niino M; Department of Clinical Research, National Hospital Organization Hokkaido Medical Center, Sapporo, Japan., Nakashima I; Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan., Miura Y; Department of Neurology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan., Yokota T; Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo, Japan.
Publikováno v:
Journal of neuroimmunology [J Neuroimmunol] 2024 Sep 15; Vol. 394, pp. 578407. Date of Electronic Publication: 2024 Jul 24.
Autor:
Kaneko K; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Kuroda H; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Matsumoto Y; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Sakamoto N; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Yamazaki N; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Yamamoto N; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Umezawa S; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Namatame C; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Ono H; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Takai Y; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Takahashi T; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Fujimori J; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Nakashima I; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Harigaya Y; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Lassmann H; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Fujihara K; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Misu T; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria., Aoki M; From the Department of Neurology (K.K., H.K., Y.M., N.S., N. Yamazaki, N. Yamamoto, S.U., C.N., H.O., Y.T., T.T., K.F., T.M., M.A.), Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis and Neuromyelitis Optica Center (H.K., K.F.), Southern TOHOKU Research Institute for Neuroscience, Koriyama; Department of Multiple Sclerosis Therapeutics (H.K., K.F.), Fukushima Medical University, Fukushima, Japan; Department of Neurology (T.T.), NHO Yonezawa National Hospital, Yamagata, Japan; Division of Neurology (J.F., I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Neurology (Y.H.), Japanese Redcross Maebashi Hospital; Department of Neurology (Y.H.), Mihara Memorial Hospital, Isesaki, Japan; and Center for Brain Research (H.L.), Medical University of Vienna, Austria.
Publikováno v:
Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2024 Sep; Vol. 11 (5), pp. e200293. Date of Electronic Publication: 2024 Aug 12.
Autor:
Akaishi T; Department of Neurology, Tohoku University, Sendai, Japan., Nakashima I; Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Publikováno v:
Neural regeneration research [Neural Regen Res] 2024 Sep 01; Vol. 19 (9), pp. 1888-1889. Date of Electronic Publication: 2023 Dec 15.
Autor:
Yamashita K; School of Medicine, Tohoku Medical and Pharmaceutical University, Japan., Miyazawa K; Division of Neurology, Tohoku Medical and Pharmaceutical University, Japan., Murakami K; Division of Pathology, Tohoku Medical and Pharmaceutical University, Japan., Nakashima I; Division of Neurology, Tohoku Medical and Pharmaceutical University, Japan.
Publikováno v:
Internal medicine (Tokyo, Japan) [Intern Med] 2024 Jul 01; Vol. 63 (13), pp. 1939-1943. Date of Electronic Publication: 2023 Nov 27.
Autor:
Akaishi T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan., Fujimori J; Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan. Electronic address: j-fujimori@tohoku-mpu.ac.jp., Yokote H; Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo, Japan., Nakashima I; Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Publikováno v:
Clinical neurology and neurosurgery [Clin Neurol Neurosurg] 2024 Jul; Vol. 242, pp. 108342. Date of Electronic Publication: 2024 May 17.
Autor:
Nakashima I; Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan. Electronic address: nakashima@tohoku-mpu.ac.jp., Nakahara J; Department of Neurology, Keio University School of Medicine, Tokyo, Japan., Yasunaga H; Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan., Yamashita M; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan., Nishijima N; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan., Satomura A; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan., Nio M; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan., Fujihara K; Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, Koriyama, Japan; Multiple Sclerosis and Neuromyelitis Optica Center, Southern Tohoku Research Institute for Neuroscience, Koriyama, Japan.
Publikováno v:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Apr; Vol. 84, pp. 105502. Date of Electronic Publication: 2024 Feb 12.
Autor:
Akaishi T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan. Electronic address: t-akaishi@med.tohoku.ac.jp., Misu T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan., Takahashi T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurology, National Hospital Organization Yonezawa National Hospital, Yonezawa, Japan., Fujihara K; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan; Multiple Sclerosis Therapeutics, Fukushima Medical University, Fukushima, Japan., Fujimori J; Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan., Nakashima I; Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan., Aoki M; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Publikováno v:
Clinical neurology and neurosurgery [Clin Neurol Neurosurg] 2024 Apr; Vol. 239, pp. 108224. Date of Electronic Publication: 2024 Mar 02.
Autor:
Fujimori J; Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan., Nakashima I; Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Publikováno v:
Heliyon [Heliyon] 2024 Mar 18; Vol. 10 (6), pp. e28136. Date of Electronic Publication: 2024 Mar 18 (Print Publication: 2024).